Novavax
NVAX
#5751
Rank
NZ$1.94 B
Marketcap
NZ$11.96
Share price
0.73%
Change (1 day)
-15.23%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.43 Billion

According to Novavax's latest financial reports the company's total debt is NZ$0.43 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.40 B12.79%
2023-12-31NZ$0.36 B-58.17%
2022-12-31NZ$0.86 B30.28%
2021-12-31NZ$0.66 B2.48%
2020-12-31NZ$0.64 B35.71%
2019-12-31NZ$0.47 B0.44%
2018-12-31NZ$0.47 B6.35%
2017-12-31NZ$0.44 B-2.03%
2016-12-31NZ$0.45 B79029.35%
2015-12-31NZ$0.57 M-54.69%
2014-12-31NZ$1.27 M-44.35%
2013-12-31NZ$2.28 M56.27%
2012-12-31NZ$1.46 M257.25%
2011-12-31NZ$0.41 M-20.92%
2010-12-31NZ$0.51 M-22.51%
2009-12-31NZ$0.66 M-98.3%
2008-12-31NZ$39.47 M32.92%
2007-12-31NZ$29.69 M-9.77%
2006-12-31NZ$32.91 M-26.31%
2005-12-31NZ$44.66 M-14.24%
2004-12-31NZ$52.08 M-19.7%
2003-12-31NZ$64.86 M-18.01%
2002-12-31NZ$79.11 M-4.33%
2001-12-31NZ$82.68 M83.22%
2000-12-31NZ$45.13 M23485.6%
1999-12-31NZ$0.19 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
NZ$79.22 M-81.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$2.16 B 397.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.14 B 164.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$1.11 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$56.48 B 12,893.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$105.32 B 24,128.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$55.43 B 12,650.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
NZ$2.59 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$41.30 B 9,401.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
NZ$4.53 M-98.96%๐Ÿ‡บ๐Ÿ‡ธ USA